Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
D. C. Morris, M. Chopp, L. Zhang, and Z. G. Zhang, Thymosin 4: a candidate for treatment of stroke?, Wiley, May 2010. doi: 10.1111/j.1749-6632.2010.05469.x
Final Takeaway BPC-157 is a promising laboratory molecule, not a proven medical treatment
Pevec et al
intravenous TB-4 Phase 1 safety and pharmacokinetics, no dose-limiting or serious adverse events (Ann N Y Acad Sci 2010;1194:223229): NCT00743769 On February 27, 2026, HHS Secretary Kennedy announced that GHK-Cu is among approximately 14 peptides expected to return to Category 1
Reconstituted BPC-157 in bacteriostatic water maintains structural integrity for approximately 21-28 days when stored at 2-8C and protected from light
- What is the current evidence for the use of BPC 157
US$ 25.34
US$ 26.60
US$ 28.05
US$ 22.88
US$ 21.45
US$ 29.15
US$ 26.66
US$ 27.83
US$ 21.33
US$ 20.06
US$ 28.41
US$ 24.86
